MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2020

    Exploring cognitive aspect of linguistic prosody in Parkinson’s disease

    A. Basirat, S. Pinto, K. Dujardin, L. Defebvre, D. Devos, C. Moreau (Lille, France)

    Objective: To explore the correlation between linguistic prosody and cognition in Parkinson's disease Background: Around 90% of patients with Parkinson’s disease (PD) report speech deficit.…
  • MDS Virtual Congress 2020

    Pareidolias and Cognition in Isolated REM Sleep Behavior Disorder

    L. Honeycutt, J.F Gagnon, A. Pelletier, J. De Roy, J. Montplaisir, R. Postuma (Montreal, QC, Canada)

    Objective: The objective of this study is to investigate the relationship between errors on the pareidolia test and global cognition in patients with REM sleep…
  • MDS Virtual Congress 2020

    Cerebrospinal fluid protein markers of cognition in early Parkinson’s disease

    I. Markaki, S. Bergström, P. Tsitsi, J. Remnestål, A. Månberg, E. Hertz, W. Paslawski, M. Uhlen, G. Mangone, S. Carvalho, O. Rascol, W. Meissner, E. Magnin, U. Wüllner, J.C Corvol, P. Nilsson, P. Svenningsson (Besancon, France)

    Objective: The aim of this multicenter study was to investigate potential alterations of CSF protein levels associated with overall and domain-specific cognitive performance in early…
  • MDS Virtual Congress 2020

    Predictors of different progressive trajectories of cognition in Parkinson’s disease

    G. Smith, R. Zielinski, C. Venuto, M. Javidnia, K. Kieburtz (Rochester, NY, USA)

    Objective: To identify subgroups of people living with Parkinson’s disease (PD) who have statistically distinct trajectories of Montreal Cognitive Assessment (MoCA) scores over four years,…
  • MDS Virtual Congress 2020

    ADAM10 polymorphisms are not associated with susceptibility to Parkinson’s disease and Parkinson’s disease with cognitive impairment in a Chinese cohort

    P. Zhang, Y. Li, L.J Wang, Y.H Zhang (Guangzhou, China)

    Objective: This study is to explore the relationship between the rs442495 and rs593742 loci of ADAM10 gene and Parkinson's disease( PD) or PD cognitive impairment.…
  • MDS Virtual Congress 2020

    Neural Correlates of Semantic Fluency Deficits in Parkinson’s Disease with Mild Cognitive Impairment

    J. Yang, G. Byrne, J. O'Sullivan, K. McMahon, D. Copland, N. Dissanayaka (Herston, Australia)

    Objective: To explore neural mechanisms related to semantic fluency deficits in Parkinson’s disease (PD). Background: Verbal fluency impairments are the earliest and typical cognitive deficits…
  • MDS Virtual Congress 2020

    Vitamin D assessment in patents with Parkinson’s disease

    N.A Mansurova, Y.N Madjidova (Tashkent, Uzbekistan)

    Objective: Analysis of the effectiveness of vitamin D in patients with PD depending on clinical manifestations and concentration levels of 25 (OH) D. Background: Recent…
  • MDS Virtual Congress 2020

    TAU pathology contributes to specific patterns of structural brain damage and neuropsychological heterogeneity in Huntington’s disease

    S. Martinez-Horta, J. Perez-Perez, R. Perez-Gonzalez, A. Horta-Barba, F. Sampedro, E. Rivas-Asensio, T. Xucla, M. Guasch, A. Campolongo, C. Izquierdo-Barrionuevo, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: Explore the associations between CSF levels of neurofilament light chain (Nfl), total TAU (tTAU) and phosphorylated TAU (pTAU), structural brain damage and cognitive performance…
  • MDS Virtual Congress 2020

    White Matter Changes and Early Cognitive Impairment in Parkinson’s Disease

    T. Belal, S. Elgamal (Mansoura, Egypt)

    Objective: Studying white matter changes in Parkinson's disease patients using diffusion tensor imaging; and its relation to cognition and motor symptoms impairment. Background: Cognitive dysfunction…
  • MDS Virtual Congress 2020

    The effect of Deep Brain Stimulation in patients with Parkinson’s Disease on the Brain Cognitive Functions

    A. Ivashynka, A. Cucovici (Novara, Italy)

    Objective: To evaluate the effect of Deep Brain Stimulation (DBS) on cognitive functions and affective symptoms in patients with Parkinson's Disease (PD). Background: DBS helps…
  • « Previous Page
  • 1
  • …
  • 59
  • 60
  • 61
  • 62
  • 63
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley